An Alternative to JAK Inhibitors May Be on the Way for Alopecia Areata
My AccountFIND A DOCTORNewsCelebrityNew LaunchesTreatment & FDA NewsIndustry & Retail NewsFaceAcneAnti-AgingCelebrityEye CareHyperpigmentationMakeupSensitive SkinSkin CareSmileSun CareTreatmentsNeurotoxinsFillersLasers & Energy DevicesMicroneedlingPost-Procedure Skin CareRegenerative AestheticsSkin ConditionsSkin Lifting and TighteningBodySkin CareBody SculptingBreastsButtsCelluliteFragranceHands + NailsLegsPregnancyHairBond RepairCelebrity HairDry HairFrizzy HairGray HairHair ColorHair GrowthHair RepairScalp HealthTips + TutorialsAwardsNB100 Awards16th Annual Beauty Awards2025 NewBeauty Readers’ Choice AwardsShoppingBeautyReportGift GuidesNewBeauty StorefrontProduct ReviewsWellnessFitnessGLP-1sHealthMenopauseNewBeauty RXBEAUTYPASSNewsView All NewsCelebrityNew LaunchesTreatment & FDA NewsIndustry & Retail NewsFaceView All FaceAcneAnti-AgingCelebrityEye CareHyperpigmentationMakeupSensitive SkinSkin CareSmileSun CareTreatmentsView All TreatmentsNeurotoxinsFillersLasers & Energy DevicesMicroneedlingPost-Procedure Skin CareRegenerative AestheticsSkin ConditionsSkin Lifting and TighteningBodyView All BodySkin CareBody SculptingBreastsButtsCelluliteFragranceHands + NailsLegsPregnancyHairView All HairBond RepairCelebrity HairDry HairFrizzy HairGray HairHair ColorHair GrowthHair RepairScalp HealthTips + TutorialsAwardsView All AwardsNB100 Awards16th Annual Beauty Awards2025 NewBeauty Readers’ Choice AwardsShoppingView All ShoppingBeautyReportGift GuidesNewBeauty StorefrontProduct ReviewsWellnessView All WellnessFitnessGLP-1sHealthMenopauseNewBeauty RXLoading…FIND A DOCTORBEAUTYPASS Advertisement Home›Hair Loss An Alternative to JAK Inhibitors May Be on the Way for Alopecia Areata A new antibody treatment shows encouraging early hair regrowth results. Alopecia areata has a frustrating pattern: hair falls out, sometimes grows back, then falls out again, often with no clear answers for people who’ve already tried the standard treatments. Now there’s a new name to know when it comes to treatment. Bempikibart, an experimental antibody treatment, is showing encouraging early signs of regrowth, even in patients whose alopecia didn’t respond well to JAK inhibitors, one of today’s most common alopecia areata treatments. As reported by Dermatology Times, Q32 Bio recently announced 36-week results from Part B of its SIGNAL-AA phase 2a trial. The open-label trial enrolled 33 patients with severe or very severe alopecia areata, defined as 50 to 100 percent scalp hair loss, with a current episode lasting no more than four years. Patients started on weekly injections of bempikibart for four weeks, then moved to injections every other week through week 36. Enrollment actually ran higher than planned; demand from patients pushed it past…